IGM Biosciences (IGMS) Competitor Comparison
We are evaluating the key criteria listed to compare IGM Biosciences (IGMS) against its competitors in the Biotechnology industry.
Market Capitalization
137 / 368Gross Profits
130 / 278Total Revenue
225 / 300EBITDA
295 / 337Free Cashflow
301 / 352Quick Ratio
93 / 357Earnings per Share
266 / 359Dividend yield
0 / 6Total Cash
79 / 358Performance 3 years
239 / 368Performance 5 years
172 / 368Performance 10 years
130 / 368Linearity 3 years
251 / 368Linearity 5 years
61 / 368Linearity 10 years
34 / 368Total Rank
149 / 368Dividend Rank
153 / 368Valuation Rank
49 / 368Piotroski Rank
77 / 368Muliplier Rank
361 / 368Performance 3 years - IGMS ranking 239 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.